Cargando…

Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation

BACKGROUND: Patients with T cell deficiency <10% of normal proliferation are indicated to receive immune reconstruction by hematopoietic stem cell transplantation (HSCT). This study aimed to investigate whether non-radioactive assays can be used to quantitatively detect the lymphocyte proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hsin-Ju, Gau, Chun-Chun, Lee, Wan-Fang, Lee, Wen-I, Huang, Jing-Long, Chen, Shih-Hsiang, Yeh, Ho-Yu, Liang, Chi-Jou, Fu, Shih-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082031/
https://www.ncbi.nlm.nih.gov/pubmed/35547552
http://dx.doi.org/10.3389/fped.2022.638549
_version_ 1784703121004429312
author Lee, Hsin-Ju
Gau, Chun-Chun
Lee, Wan-Fang
Lee, Wen-I
Huang, Jing-Long
Chen, Shih-Hsiang
Yeh, Ho-Yu
Liang, Chi-Jou
Fu, Shih-Hang
author_facet Lee, Hsin-Ju
Gau, Chun-Chun
Lee, Wan-Fang
Lee, Wen-I
Huang, Jing-Long
Chen, Shih-Hsiang
Yeh, Ho-Yu
Liang, Chi-Jou
Fu, Shih-Hang
author_sort Lee, Hsin-Ju
collection PubMed
description BACKGROUND: Patients with T cell deficiency <10% of normal proliferation are indicated to receive immune reconstruction by hematopoietic stem cell transplantation (HSCT). This study aimed to investigate whether non-radioactive assays can be used to quantitatively detect the lymphocyte proliferation <10% of normal as radioactive [(3)H]-thymidine.” METHODS: Radioactive [(3)H]-thymidine, non-radioactive carboxyfluorescein diacetate succinimidyl ester (CFSE), and Ki-67 protein expressions were used to measure the lymphocyte proliferation as calculated using the stimulation index (SI), subtraction percentage, and proliferation index (FlowJo software). Normal references were established for comparison in the absence of parallel healthy controls. RESULTS: Normal ranges of mitogen-stimulated lymphocyte proliferation were established as a SI of 15–267 (CSFE 47–92%, Ki-67 42–79%) with phytohemagglutinin (PHA) 5 μg/ml stimulation; 19–139 (CFSE 62–83%, 45–74% Ki-67) with concanavalin-A (ConA) 5 μg/ml stimulation; 7–53 (CFSE 6–23%, Ki-67 10–24%) with pokeweed mitogen (PWM) 0.1 ug/ml stimulation; 3–28 (CFSE 4–10%, Ki-67 5–14%) with candida 10 ug/ml stimulation; and 2–27 (CFSE 6–41%, Ki-67 6–30%) with bacille Calmette-Guerin (BCG) 0.02 ng/ml stimulation. The normalized CFSE-proliferation index was between 2.1 and 3.0. Although there was no significant correlation between these three assays in the healthy controls, the SI value for <10% [(3)H]-thymidine proliferation in those with T cell deficiency was compatible with CFSE- and Ki-67-stained lymphocyte percentages, and validated in patients with IL2RG, RAG1, and ZAP70 mutations. When calculating [(3)H]-thymidine <10% of normal lymphocyte proliferation, the threshold of parallel controls was more reliable than previously established normal references. CONCLUSION: The large quantitative value of radioactive [(3)H]-thymidine was more easily recognizable than that for non-radioactive CFSE and Ki-67. Even though the correlation was not significant, those identified to have <10% of normal proliferation by [(3)H]-thymidine could be consistently detected by CFSE and Ki-67, and consequently indicated for HSCT.
format Online
Article
Text
id pubmed-9082031
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90820312022-05-10 Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation Lee, Hsin-Ju Gau, Chun-Chun Lee, Wan-Fang Lee, Wen-I Huang, Jing-Long Chen, Shih-Hsiang Yeh, Ho-Yu Liang, Chi-Jou Fu, Shih-Hang Front Pediatr Pediatrics BACKGROUND: Patients with T cell deficiency <10% of normal proliferation are indicated to receive immune reconstruction by hematopoietic stem cell transplantation (HSCT). This study aimed to investigate whether non-radioactive assays can be used to quantitatively detect the lymphocyte proliferation <10% of normal as radioactive [(3)H]-thymidine.” METHODS: Radioactive [(3)H]-thymidine, non-radioactive carboxyfluorescein diacetate succinimidyl ester (CFSE), and Ki-67 protein expressions were used to measure the lymphocyte proliferation as calculated using the stimulation index (SI), subtraction percentage, and proliferation index (FlowJo software). Normal references were established for comparison in the absence of parallel healthy controls. RESULTS: Normal ranges of mitogen-stimulated lymphocyte proliferation were established as a SI of 15–267 (CSFE 47–92%, Ki-67 42–79%) with phytohemagglutinin (PHA) 5 μg/ml stimulation; 19–139 (CFSE 62–83%, 45–74% Ki-67) with concanavalin-A (ConA) 5 μg/ml stimulation; 7–53 (CFSE 6–23%, Ki-67 10–24%) with pokeweed mitogen (PWM) 0.1 ug/ml stimulation; 3–28 (CFSE 4–10%, Ki-67 5–14%) with candida 10 ug/ml stimulation; and 2–27 (CFSE 6–41%, Ki-67 6–30%) with bacille Calmette-Guerin (BCG) 0.02 ng/ml stimulation. The normalized CFSE-proliferation index was between 2.1 and 3.0. Although there was no significant correlation between these three assays in the healthy controls, the SI value for <10% [(3)H]-thymidine proliferation in those with T cell deficiency was compatible with CFSE- and Ki-67-stained lymphocyte percentages, and validated in patients with IL2RG, RAG1, and ZAP70 mutations. When calculating [(3)H]-thymidine <10% of normal lymphocyte proliferation, the threshold of parallel controls was more reliable than previously established normal references. CONCLUSION: The large quantitative value of radioactive [(3)H]-thymidine was more easily recognizable than that for non-radioactive CFSE and Ki-67. Even though the correlation was not significant, those identified to have <10% of normal proliferation by [(3)H]-thymidine could be consistently detected by CFSE and Ki-67, and consequently indicated for HSCT. Frontiers Media S.A. 2022-04-25 /pmc/articles/PMC9082031/ /pubmed/35547552 http://dx.doi.org/10.3389/fped.2022.638549 Text en Copyright © 2022 Lee, Gau, Lee, Lee, Huang, Chen, Yeh, Liang and Fu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Lee, Hsin-Ju
Gau, Chun-Chun
Lee, Wan-Fang
Lee, Wen-I
Huang, Jing-Long
Chen, Shih-Hsiang
Yeh, Ho-Yu
Liang, Chi-Jou
Fu, Shih-Hang
Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation
title Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation
title_full Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation
title_fullStr Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation
title_full_unstemmed Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation
title_short Comparison of [(3)H]-Thymidine, Carboxyfluorescein Diacetate Succinimidyl Ester and Ki-67 in Lymphocyte Proliferation
title_sort comparison of [(3)h]-thymidine, carboxyfluorescein diacetate succinimidyl ester and ki-67 in lymphocyte proliferation
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082031/
https://www.ncbi.nlm.nih.gov/pubmed/35547552
http://dx.doi.org/10.3389/fped.2022.638549
work_keys_str_mv AT leehsinju comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT gauchunchun comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT leewanfang comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT leeweni comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT huangjinglong comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT chenshihhsiang comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT yehhoyu comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT liangchijou comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation
AT fushihhang comparisonof3hthymidinecarboxyfluoresceindiacetatesuccinimidylesterandki67inlymphocyteproliferation